-
Signature
-
/s/ Ali Olivo, Attorney-in-Fact
-
Stock symbol
-
NEO
-
Transactions as of
-
Mar 4, 2024
-
Transactions value $
-
-$97,579
-
Form type
-
4
-
Date filed
-
3/6/2024, 04:26 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
NEO |
Common Stock |
Sale |
-$97.6K |
-6.11K |
-10.88% |
$15.97 |
50.1K |
Mar 4, 2024 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
holding |
NEO |
Stock Option (Right to Buy) |
|
|
|
|
|
2.14K |
Mar 4, 2024 |
Common Stock |
2.14K |
$22.52 |
Direct |
|
holding |
NEO |
Stock Option (Right to Buy) |
|
|
|
|
|
3.45K |
Mar 4, 2024 |
Common Stock |
3.45K |
$28.54 |
Direct |
|
holding |
NEO |
Stock Option (Right to Buy) |
|
|
|
|
|
3.71K |
Mar 4, 2024 |
Common Stock |
3.71K |
$40.90 |
Direct |
|
holding |
NEO |
Stock Option (Right to Buy) |
|
|
|
|
|
972 |
Mar 4, 2024 |
Common Stock |
972 |
$41.76 |
Direct |
|
holding |
NEO |
Stock Option (Right to Buy) |
|
|
|
|
|
13.9K |
Mar 4, 2024 |
Common Stock |
13.9K |
$8.10 |
Direct |
|
holding |
NEO |
Stock Option (Right to Buy) |
|
|
|
|
|
8.35K |
Mar 4, 2024 |
Common Stock |
8.35K |
$14.82 |
Direct |
|
holding |
NEO |
Restricted Stock Unit |
|
|
|
|
|
11.3K |
Mar 4, 2024 |
Common Stock |
11.3K |
$0.00 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: